Clinical Trial Update: Tolerability and Pharmacokinetics(PK)/Pharmacodynamics(PD) Study of GW003 in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating tolerability and PK/PD of GW003 in healthy subjects, conducted to support chemotherapy-induced neutropenia treatment; the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Neutropenia

Drugs mentioned

• GW003

Snippet

Sponsor: Jiangsu T-Mab Biopharma Co.,Ltd | Conditions: Chemotherapy-induced Neutropenia | Phase 1 | Status: COMPLETED